Undergo dose autologous peripheral blood stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy26

Hematopoietic Stem Cells Stem Cells Blood Cells Leukocytes, Mononuclear T-Lymphocytes Bone Marrow Cells, Cultured Lymphocyte Subsets Embryonic Stem Cells Bone Marrow Cells Adult Stem Cells Lymphocytes Fetal Blood Antilymphocyte Serum Pluripotent Stem Cells Killer Cells, Natural Mesenchymal Stromal Cells Neural Stem Cells Induced Pluripotent Stem Cells Neoplastic Cells, Circulating Granulocytes T-Lymphocytes, Cytotoxic Multipotent Stem Cells Fetal Stem Cells Clone Cells Neutrophils

Organisms4

Transplantation Chimera Cytomegalovirus Mice, Inbred C57BL Mice, SCID

Diseases44

Hematologic Neoplasms Multiple Myeloma Graft vs Host Disease Lymphoma, Non-Hodgkin Recurrence Amyloidosis Hodgkin Disease Neoplasms Infection Lymphoma, T-Cell POEMS Syndrome Leukemia, Myeloid, Acute Leukemia Lymphoma Cytomegalovirus Infections Myelodysplastic Syndromes Anemia, Aplastic Leukemia, Myelogenous, Chronic, BCR-ABL Positive Histiocytosis, Non-Langerhans-Cell Livedo Reticularis Hematologic Diseases Opportunistic Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Breast Neoplasms Fever Bone Marrow Diseases Neoplasm, Residual Blood Group Incompatibility Acute Disease Neuroblastoma Chronic Disease Neutropenia Leukemia, Myeloid Hepatic Veno-Occlusive Disease Leukemia, Myelomonocytic, Acute Neoplastic Cells, Circulating Wiskott-Aldrich Syndrome Neoplasm Recurrence, Local Lymphoproliferative Disorders Thrombocytopenia Sarcoma, Ewing Neoplasms, Second Primary Stomatitis Severe Combined Immunodeficiency

Chemicals and Drugs45

Melphalan Granulocyte Colony-Stimulating Factor Antigens, CD34 Cyclophosphamide Myeloablative Agonists Busulfan Etoposide Thiotepa Antineoplastic Agents, Alkylating Carmustine Ifosfamide Vincristine Cytarabine Doxorubicin Prednisone Carboplatin Immunosuppressive Agents Dexamethasone Vidarabine Recombinant Proteins Antineoplastic Agents HLA Antigens Cyclosporine Antigens, CD Methotrexate Granulocyte-Macrophage Colony-Stimulating Factor Epirubicin Antilymphocyte Serum Prochlorperazine Methylprednisolone Podophyllotoxin Stem Cell Factor Antibodies, Monoclonal Interleukin-2 Idarubicin Mitoxantrone Antibodies, Monoclonal, Murine-Derived Ganciclovir ABO Blood-Group System Heterocyclic Compounds Biological Markers Mesna Cytokines Antigens, CD3 Cisplatin

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Peripheral Blood Stem Cell Transplantation Transplantation, Autologous Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Transplantation Conditioning Transplantation, Homologous Leukapheresis Combined Modality Therapy Blood Component Removal Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Bone Marrow Transplantation Remission Induction Salvage Therapy Disease-Free Survival Cord Blood Stem Cell Transplantation Retrospective Studies Survival Rate Whole-Body Irradiation Survival Analysis Platelet Count Histocompatibility Testing Transplantation, Isogeneic Blood Cell Count Follow-Up Studies Bone Marrow Purging Prospective Studies Fatal Outcome Feasibility Studies Immunophenotyping Blood Transfusion, Autologous Liver Transplantation Lymphocyte Depletion Prognosis Immunosuppression Mesenchymal Stem Cell Transplantation Cell Separation Pilot Projects Flow Cytometry Cell Transplantation Immunomagnetic Separation Leukocyte Count Kidney Transplantation Lymphocyte Transfusion Platelet Transfusion Polymerase Chain Reaction Incidence Leukocyte Transfusion Colony-Forming Units Assay Life Tables Lymphocyte Count Donor Selection Risk Factors Cell Count Lymphocyte Activation Heart Transplantation Tissue and Organ Harvesting Cryopreservation Lung Transplantation Organ Transplantation Transplantation Blood Preservation Drug Administration Schedule Erythrocyte Transfusion Islets of Langerhans Transplantation Cell Culture Techniques Transplantation, Heterologous Multivariate Analysis Matched-Pair Analysis Catheterization, Central Venous Pancreas Transplantation Reverse Transcriptase Polymerase Chain Reaction

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes26

Graft Survival Cytophagocytosis Hematopoiesis Time Factors Histocompatibility Platelet Count Blood Cell Count Graft vs Leukemia Effect Leukocyte Count Transplantation Immunology Graft vs Tumor Effect Cell Differentiation Lymphocyte Count Cell Count Lymphocyte Activation Chimerism Graft Rejection Stem Cell Niche Immunocompromised Host Cell Lineage Dose-Response Relationship, Drug Cytotoxicity, Immunologic Cell Survival Cell Proliferation Virus Activation Regeneration

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Blood Donors Siblings Unrelated Donors Living Donors

Health Care17

Treatment Outcome Disease-Free Survival Retrospective Studies Survival Rate Survival Analysis Follow-Up Studies Prospective Studies Fatal Outcome Feasibility Studies Pilot Projects Incidence Life Tables Donor Selection Risk Factors Safety Multivariate Analysis Matched-Pair Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Peripheral Blood Stem Cell Transplantation Transplantation, Autologous Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Transplantation Conditioning Transplantation, Homologous Melphalan Granulocyte Colony-Stimulating Factor Leukapheresis Combined Modality Therapy Hematologic Neoplasms Antigens, CD34 Blood Component Removal Stem Cell Transplantation Cyclophosphamide Multiple Myeloma Antineoplastic Combined Chemotherapy Protocols Myeloablative Agonists Busulfan Graft vs Host Disease Treatment Outcome Lymphoma, Non-Hodgkin Graft Survival Bone Marrow Transplantation Hematopoietic Stem Cells Etoposide Thiotepa Antineoplastic Agents, Alkylating Remission Induction Recurrence Cytophagocytosis Carmustine Ifosfamide Salvage Therapy Vincristine Amyloidosis Stem Cells Cytarabine Hematopoiesis Hodgkin Disease Disease-Free Survival Cord Blood Stem Cell Transplantation Transplantation Chimera Neoplasms Retrospective Studies Tissue Donors Survival Rate Whole-Body Irradiation Infection Survival Analysis Lymphoma, T-Cell Time Factors Doxorubicin Histocompatibility POEMS Syndrome Platelet Count Prednisone Carboplatin Histocompatibility Testing Immunosuppressive Agents Leukemia, Myeloid, Acute Transplantation, Isogeneic Dexamethasone Vidarabine Blood Cell Count Recombinant Proteins Follow-Up Studies Leukemia Antineoplastic Agents Bone Marrow Purging Lymphoma Cytomegalovirus Infections Prospective Studies Blood Cells Graft vs Leukemia Effect Fatal Outcome Feasibility Studies Myelodysplastic Syndromes Immunophenotyping Anemia, Aplastic Blood Transfusion, Autologous Liver Transplantation Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphocyte Depletion Leukocytes, Mononuclear T-Lymphocytes Histiocytosis, Non-Langerhans-Cell Livedo Reticularis Hematologic Diseases Opportunistic Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Bone Marrow HLA Antigens Cyclosporine Prognosis Blood Donors Breast Neoplasms Immunosuppression Mesenchymal Stem Cell Transplantation Cell Separation

No FAQ available that match "undergo dose autologous peripheral blood stem cell transplantation"